Cargando…

Consucrats Have Agency: What Next for the Profecrat? Comment on "The Rise of the Consucrat"

The trend in ensuring adequate consumer representation across diverse activities and sectors, not least in healthcare, has been speedily implemented, sometimes at the expense of strategy. This commentary explores the concept of the consucrat as a consumer representative, presented by de Leeuw, which...

Descripción completa

Detalles Bibliográficos
Autor principal:	Keeling, Debbie Isobel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kerman University of Medical Sciences 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056198/ https://www.ncbi.nlm.nih.gov/pubmed/34060268 http://dx.doi.org/10.34172/ijhpm.2021.41

Ejemplares similares

Patient, Public, Consumer, and Community Engagement: From Consucrat to Representative Comment on "The Rise of the Consucrat"
por: DeCamp, Matthew, et al.
Publicado: (2020)

The Rise of the Consucrat
por: de Leeuw, Evelyne
Publicado: (2020)

The Pandemic, Patient Advocacy, and the Importance of Thinking Comment on "The Rise of the Consucrat"
por: O’Donovan, Órla
Publicado: (2020)

Consucrats and Pathocrats: The Prequel, Quel, and Sequel; A Response to the Recent Commentaries
por: de Leeuw, Evelyne
Publicado: (2021)

Moral Lacunae in the Management of Dual Agency Dilemmas: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Lipworth, Wendy
Publicado: (2022)

Dual Goals, Dual Agency: The Perils of Measurement and Control: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Greve, Henrich R.
Publicado: (2022)

Understanding Structure and Agency as Commercial Determinants of Health: Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention"
por: Lee, Kelley, et al.
Publicado: (2019)

Systems Science and Evidence-Informed Deliberation to Mitigate Dilemmas in Situations of Dual Agency at the Hospital Level: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations"
por: Bijlmakers, Leon
Publicado: (2022)

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Schlander, Michael
Publicado: (2020)

Navigating Dichotomies and Dilemmas: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Sirris, Stephen
Publicado: (2022)

Neoliberalism 4.0: The Rise of Illiberal Capitalism: Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention"
por: Labonté, Ronald
Publicado: (2019)

The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017–2022
por: Hallinan, Christine Mary, et al.
Publicado: (2022)

The Dilemmas of Leading Health Organizations in Complex Settings: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Greener, Ian
Publicado: (2022)

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Gopinathan, Unni, et al.
Publicado: (2020)

History, Structure and Agency in Global Health Governance: Comment on "Global Health Governance Challenges 2016 – Are We Ready?"
por: Gill, Stephen, et al.
Publicado: (2016)

If It Is Complex, Let It Be Complex – Dealing With Institutional Complexity in Hospitals: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Andersson, Thomas
Publicado: (2022)

The Future of Biobanking: What Is Next?
por: Caenazzo, Luciana, et al.
Publicado: (2020)

Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Goetghebeur, Mireille, et al.
Publicado: (2020)

Regulatory agencies have a role to play in maintaining consumer confidence in vaccine safety for pregnant women
por: Giles, Michelle L., et al.
Publicado: (2020)

Skin Sensitization Testing—What’s Next?
por: Grundström, Gunilla, et al.
Publicado: (2019)

Next Steps for Elevating Health on Trade and Investment Policy Agendas: Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention"
por: Townsend, Belinda
Publicado: (2019)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
por: Madbouly, Khaled
Publicado: (2013)

The Far Right Challenge: Comment on "The Rise of Post-truth Populism in Pluralist Liberal Democracies: Challenges for Health Policy"
por: Halikiopoulou, Daphne
Publicado: (2017)

Hospital Professionals as Dual Agents: A Superordinate Identity to Solve Interprofessional Conflicts in Hospitals?: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Cascón-Pereira, Rosalía
Publicado: (2022)

Endothelin antagonists in subarachnoid hemorrhage: what next?
por: Macdonald, R Loch
Publicado: (2012)

Mapping the Human Brain: What Is the Next Frontier?
por: Fan, Lingzhong
Publicado: (2020)

Pharmacovigilance and the Italian Medicines Agency
por: Pimpinella, Giuseppe, et al.
Publicado: (2013)

Aiming for agency and authenticity in assessment
por: Harrison, Christopher
Publicado: (2018)

New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Parvizi, Nassim, et al.
Publicado: (2017)

In Need of Renewal Rather Than Reconciliation: Why We Cannot Be Satisfied With Hospital Management’s Status Quo: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Ewert, Benjamin
Publicado: (2022)

The Bright Elusive Butterfly of Value in Health Technology Development: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Greenhalgh, Trisha, et al.
Publicado: (2017)

The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Buttigieg, Sandra C., et al.
Publicado: (2017)

Use of Evidence-Informed Deliberative Processes – Learning by Doing: Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Culyer, Anthony J.
Publicado: (2019)

Fluid resuscitation in the critically ill: what is the next challenge?
por: Hammond, Naomi, et al.
Publicado: (2015)

Evidence-Based Policymaking: What Human Service Agencies Can Learn from Implementation Science and Integrated Data Systems
por: Zanti, Sharon, et al.
Publicado: (2021)

Rise and rise of anesthesiologists under the shadow of COVID-19
por: Gondode, Prakash Gyandev, et al.
Publicado: (2021)

Decisions by regulatory agencies: are they evidence-based?
por: Furberg, Curt D
Publicado: (2007)

Comment: A sustainable and equitable response to the cost-of-living crisis is urgently needed
por: Mulrenan, Claire, et al.
Publicado: (2023)

The rising dominance of microbiology: what to expect in the next 15 years?
por: Kumar, Roshan, et al.
Publicado: (2021)

This Is My (Post) Truth, Tell Me Yours: Comment on "The Rise of Post-truth Populism in Pluralist Liberal Democracies: Challenges for Health Policy"
por: Powell, Martin
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_paiiopsfthod6q82a8dg4lt8qe